EPIC SCIENCES’ DefineMBC™ TEST DELIVERS COMPREHENSIVE LIQUID BIOPSY RESULTS FOR METASTATIC BREAST CANCER

20 US Clinical Cancer Centers, 16 Metastatic Breast Cancer Trials now powered by Epic Sciences platform DefineMBC™ assesses breast cancer as it evolves in later stages and new treatments become available SAN DIEGO, May 4, 2022 /PRNewswire/ — Epic Sciences, Inc. has added DefineMBC™, a…

Click here to view original post